CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 300784346
- Phone
- (484) 253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 10,781 | ||
| 2026-05-20 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 10,740 | ||
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,502 | $125.96 | $189K | 2,800 |
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,500 | $127.13 | $191K | 1,300 |
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −561 | $128.23 | $72K | 739 |
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −639 | $129.17 | $83K | 100 |
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −100 | $130.33 | $13K | 0 |
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 12,935 | ||
| 2026-04-15 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 12,888 | ||
| 2026-04-13 | Doux John Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2026-03-30 | JENKINS GEORGE M Director | Purchase | +445 | $112.30 | $50K | 187,616 |
| 2026-03-18 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-03-18 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-03-18 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −2,268 | $117.56 | $267K | 2,034 |
| 2026-03-18 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,730 | $118.37 | $205K | 304 |
| 2026-03-18 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −304 | $119.08 | $36K | 0 |
| 2026-03-18 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 15,089 | ||
| 2026-03-18 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 15,036 |
Page 6 of 12 · 232 trades